Cover	1
Disclaimer
Masthead
Table of Contents
Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression	3
The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects	5
Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences	10
Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression	16
Fluoxetine: A Suitable Long-Term Treatment	24
Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events	30
Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment	34
Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder	38
Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder	43
Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder	48
Patient Perspectives on Once-Weekly Fluoxetine	53